Sputum conversion at the end of intensive phase treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection.
Aggarwal
Deepak
D
Mohapatra
P R
PR
D000995:Antitubercular Agents / Q000627:therapeutic use*; D048909:Diabetes Complications; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000302:isolation & purification; D013183:Sputum / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology
D000995:Antitubercular Agents